• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Res Med Sci . Serum level of Vitamin D is associated with COVID-19 mortality rate in hospitalized patients

tetano

Editor, Senior Moderator
J Res Med Sci


. 2021 Nov 29;26:112.
doi: 10.4103/jrms.JRMS_1151_20. eCollection 2021.
Serum level of Vitamin D is associated with COVID-19 mortality rate in hospitalized patients


Mitra Ranjbar[SUP] 1 [/SUP], Mohammad Hadi Karbalaie Niya[SUP] 2 [/SUP], Maryam Roham[SUP] 1 3 [/SUP], Nader Rezaie[SUP] 4 [/SUP], Mahdi Yadollahzadeh[SUP] 5 [/SUP], Mohsen Farrokhpour[SUP] 5 [/SUP], Mehdi Azimi[SUP] 5 [/SUP], Nima Motamed[SUP] 6 [/SUP], Dhayaneethie Perumal[SUP] 7 [/SUP], Fahimeh Safarnezhad Tameshkel[SUP] 2 [/SUP], Farahnaz Dadras[SUP] 8 [/SUP], Nahid Hashemi Madani[SUP] 9 [/SUP], Behrooz Ghanbari[SUP] 2 [/SUP], Amirhossein Faraji[SUP] 2 [/SUP], Mehdi Nikkhah[SUP] 2 [/SUP], Shahrzad Rahmani[SUP] 8 [/SUP], Fatemah Golgiri[SUP] 9 [/SUP], Seyed Yadollah Emadi[SUP] 2 [/SUP], Rowshanak Abbasi[SUP] 9 [/SUP], Iman Mohseni[SUP] 10 [/SUP], Mohammad Reza Babaei[SUP] 10 [/SUP], Ramin Eskandari[SUP] 11 [/SUP], Manizhe Ataee[SUP] 10 [/SUP], Mahshid Panahi[SUP] 2 [/SUP], Farhad Zamani[SUP] 2 [/SUP], Mahin Jamshidi Makiani[SUP] 1 3 [/SUP], Azadeh Laali[SUP] 1 3 [/SUP]



Affiliations

Abstract

Background: Due to widespread of coronavirus disease 2019 (COVID-19) infection, identification of its risk factors and clinical characteristics are important. The aim of the present study was to assess Vitamin D levels in individuals with severe acute respiratory syndrome coronavirus-19 infection and to report on its potential as a predictive marker.
Materials and methods: All patients, diagnosed with COVID-19 infection from February 16 to March 21, 2020, and referred to Firoozgar Hospital, Tehran, Iran, were enrolled in this study. Vitamin D analysis was undertaken on patient serum samples using a commercial kit (Pars Azmoon Co., Tehran, Iran). SPSS v. 22 was used for statistical analysis.
Results: Vitamin D serum concentration was analyzed in a total of 317 patients whose mean age ± standard deviation was 62.05 ± 15 years and with 62.5% being male. A significant association of Vitamin D level and death was observed. Higher levels of serum Vitamin D had protection against death (odds ratio = 0.955 [95% confidence interval = 0.923-0.988], P = 0.008).
Conclusion: As a preliminary study in the Iranian population who suffered COVID-19 disease, we identified that Vitamin D deficiency was associated with a higher death rate and intensive care unit admission.

Keywords: Coronavirus disease 2019; Vitamin D; malnutrition; respiratory tract infection.
 
Back
Top Bottom